Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gan xun Li"'
Autor:
Qian yun Ge, Jin Chen, Gan xun Li, Xiao long Tan, Jia Song, Deng Ning, Jie Mo, Peng cheng Du, Qiu meng Liu, Hui fang Liang, Ze yang Ding, Xue wu Zhang, Bi xiang Zhang
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 11, Pp n/a-n/a (2021)
Abstract Background Aberrant TAK1 (transforming growth factor β‐activated kinase 1) activity is known to be involved in a variety of malignancies, but the regulatory mechanisms of TAK1 remain poorly understood. GRAMD4 (glucosyltransferase Rab‐li
Externí odkaz:
https://doaj.org/article/53eba7c6cc954f4fae0d49a14cfacd22
Autor:
Xin Luo, Rui-zhi Chang, Dong Kuang, Mingming Yuan, Gan-xun Li, Bixiang Zhang, Yan-jun Wang, Wan-guang Zhang, Ze-yang Ding
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundAdvanced hepatocellular carcinoma (HCC) shows poor prognosis. Combined hepatic artery infusion chemotherapy (HAIC) and lenvatinib and PD-1 antibody therapy show promising effects in treating advanced HCC, and salvage hepatectomy further pro
Externí odkaz:
https://doaj.org/article/28c70b658c214bca822063085945429d
Autor:
Jing-jing Wu, Zhan-guo Zhang, Peng Zhu, Abdoul-aziz Mba'nbo-koumpa, Bi-xiang Zhang, Xiao-ping Chen, Chang Shu, Wan-guang Zhang, Ren-jie Feng, Gan-xun Li
Publikováno v:
Asian Journal of Surgery, Vol 42, Iss 9, Pp 874-882 (2019)
Summary: Background/Objective: Previous studies have proposed several objective means for liver function assessment in hepatocellular carcinoma (HCC) patients; however, their efficiency in predicting survival of HCC rupture is unknown. Our study aims
Externí odkaz:
https://doaj.org/article/f8929d8a4a7a4110a97edb90bd68132e
Autor:
Hui Fang Liang, Ze yang Ding, Qiu meng Liu, Jin Chen, Xiao long Tan, Jia Song, Deng Ning, Xuewu Zhang, Gan xun Li, Bi xiang Zhang, Jie Mo, Pengcheng Du, Qian yun Ge
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 11, Pp n/a-n/a (2021)
Clinical and Translational Medicine
Clinical and Translational Medicine
Background Aberrant TAK1 (transforming growth factor β‐activated kinase 1) activity is known to be involved in a variety of malignancies, but the regulatory mechanisms of TAK1 remain poorly understood. GRAMD4 (glucosyltransferase Rab‐like GTPase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92fd46b8807e4527e2f4b8345b54c49d
https://doi.org/10.1002/ctm2.635
https://doi.org/10.1002/ctm2.635
Autor:
Guan-nan Jin, Ze-yang Ding, Gan-xun Li, Jun-bo Hu, Ji-hong Liu, Bixiang Zhang, Xiao-ping Chen
Publikováno v:
International Journal of Medical Sciences; 2021, Vol. 18 Issue 11, p2366-2371, 6p
Autor:
Wei-xun Chen, Gan-xun Li, Zheng-nan Hu, Peng Zhu, Bi-xiang Zhang, Ze-yang Ding, Chen, Wei-Xun, Li, Gan-Xun, Hu, Zheng-Nan, Zhu, Peng, Zhang, Bi-Xiang, Ding, Ze-Yang
Publikováno v:
Medicine; Nov2019, Vol. 98 Issue 45, p1-9, 9p